Evidence map›Paper›PMID 39700258›Full record

ArticleJournal of proteome research2025

Use and Comparison of Machine Learning Techniques to Discern the Protein Patterns of Autoantibodies Present in Women with and without Breast Pathology.

José-Luis Llaguno-Roque, Rocio-Erandi Barrientos-Martínez, Héctor-Gabriel Acosta-Mesa, Antonia Barranca-Enríquez, Efrén Mezura-Montes, Tania Romo-González

Abstract readComparative Study
In one paragraph

Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

José-Luis Llaguno-RoqueLaboratorio de Biología y Salud Integral, Instituto de Investigaciones Biológicas - Universidad Veracruzana, Dr. Luis Castelazo Ayala S/N, Industrial Animas. C.P., Xalapa, Veracruz 91190, México.
Rocio-Erandi Barrientos-MartínezInstituto de Investigaciones en Inteligencia Artificial - Universidad Veracruzana, Campus Sur, Calle Paseo Lote II, Sección Segunda N° 112, Nuevo Xalapa, C.P., Xalapa, Veracruz 91097, México.
Héctor-Gabriel Acosta-MesaInstituto de Investigaciones en Inteligencia Artificial - Universidad Veracruzana, Campus Sur, Calle Paseo Lote II, Sección Segunda N° 112, Nuevo Xalapa, C.P., Xalapa, Veracruz 91097, México.
Antonia Barranca-EnríquezLaboratorio de Biología y Salud Integral, Instituto de Investigaciones Biológicas - Universidad Veracruzana, Dr. Luis Castelazo Ayala S/N, Industrial Animas. C.P., Xalapa, Veracruz 91190, México.
Efrén Mezura-MontesInstituto de Investigaciones en Inteligencia Artificial - Universidad Veracruzana, Campus Sur, Calle Paseo Lote II, Sección Segunda N° 112, Nuevo Xalapa, C.P., Xalapa, Veracruz 91097, México.ORCID 0000-0002-1565-5267
Tania Romo-GonzálezLaboratorio de Biología y Salud Integral, Instituto de Investigaciones Biológicas - Universidad Veracruzana, Dr. Luis Castelazo Ayala S/N, Industrial Animas. C.P., Xalapa, Veracruz 91190, México.ORCID 0000-0003-0097-4780

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) has become a global health problem, ranking first in incidence and fifth in mortality in women around the world. Although there are some diagnostic methods for the disease, these are not sufficiently effective and are invasive. In this work, we discriminated between patients without breast pathology (BP), with benign BP, and with BC based on the band patterns obtained from Western blot strip images of the autoantibody response to antigens of the T47D tumor line using and comparing supervised machine learning techniques to have a sensitive and accurate method. When comparing the aforementioned machine learning techniques, it was found that by obtaining a convolutional neural network architecture from a neuroevolution algorithm, it is possible to automatically discriminate with a classification accuracy of 90.67% between patients with cancer and with/without BP. In the case of discrimination between patients with cancer and without BP, a classification accuracy of 96.67% was obtained with the K-NN algorithm and 95.13% with the convolutional neural network obtained using a neuroevolution algorithm, although these results are not statistically significant. It is concluded that the convolutional neural network obtained by neuroevolution is the method with the best performance with respect to those evaluated in this work.

Indexed as

AlgorithmsAutoantibodiesBreast NeoplasmsNeural Networks, ComputerBreastCell Line, TumorFemaleHumansMachine LearningSupervised Machine LearningAutoantibodiesartificial intelligenceautoantibodiesneuroevolutiontime serieswestern blot

Identifiers

PMID39700258
PMCPMC11705216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.